AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Mar 31 2021
U.S. begins testing Moderna’s Covid vaccine booster shots for variant from South Africa
The National Institutes of Health has started testing a new coronavirus vaccine from Moderna designed to protect against a problematic variant first found in South Africa, the agency said Wednesday.
The phase one trial, led and funded by the NIH’s National Institute of Allergy and Infectious Diseases, will test how safe and effective the new shot is against the variant — known as B.1.CNBC
Mar 16 2021
Moderna Gives 1st Vaccine Shots To Young Kids As Part Of COVID-19 Study
Children have now received their first doses of Moderna's COVID-19 vaccine, as the company studies the safety and effectiveness of the vaccine for kids ages 6 months to less than 12 years old.
In the study, researchers will give two injections 28 days apart of either the Moderna vaccine or a saline placebo to children. Kids who get the vaccine will receive one of three possible doses,NPR (Online News)
Mar 12 2021
39-Year-Old Mother Dies After 2nd Dose of Moderna Vaccine: Family
A 39-year-old healthy single mother from Utah died four days after taking a second dose of the Moderna COVID-19 vaccine on Feb. 1.
According to local news channel KUTV, her family said that Kassidi Kurill, who was a surgical technician for plastic surgeons, “had more energy” than most people around her and was a happy person with no known health problems.
“I didn’t really cryThe Epoch Times
Jun 28 2021
Pfizer And Moderna Vaccines May Offer Years-Long Protection Against Covid-19, Scientists Say
Both the Pfizer-BioNTech and Moderna vaccines are likely to offer long-lasting protection against Covid-19, according to a study published on Monday, indicating that people who are already inoculated with either of the mRNA vaccines may not need a booster dose for years.Forbes
Dec 19 2020
Moderna, McKesson and U.S. Army general ready to roll out new COVID-19 vaccine
U.S. distribution of a second COVID-19 vaccine, from Moderna, is ready to start shipping to more than 3,800 sites this weekend, vastly widening the rollout begun last week with Pfizer, the drug company and distributor McKesson said.Reuters
Dec 15 2020
FDA staff endorses emergency use of Moderna’s Covid vaccine in a critical step toward approval
The staff of the Food and Drug Administration on Tuesday endorsed the emergency use of Moderna’s coronavirus vaccine, a critical step forward in winning formal clearance to be administered to the public as early as next week.
The staff report is meant to brief the FDA’s Vaccines and Related Biological Products Advisory Committee, which meets Thursday to review Moderna’s request forCNBC
Oct 29 2020
Moderna says it's on track to report initial COVID-19 vaccine results next month
Moderna is on track to report initial results from its coronavirus vaccine trial next month, company executives said Thursday.
The company is one of the front-runners to produce a vaccine for COVID-19. During an earnings call, Chief Medical Officer Tal Zaks said the trial is operating as planned, and an independent data-monitoring committee is expected to conduct an interim review inThe Hill
Nov 11 2021
Moderna says Covid vaccine has fewer breakthrough cases than Pfizer’s, but higher myocarditis rates in young men
Moderna defended the use of its Covid-19 vaccine Thursday, saying the protection it offers against severe disease, hospitalization and death outweighs the risk of myocarditis, a rare heart condition seen in a small number of young men who received the shot.
The company announced last week that the Food and Drug Administration needed more time to decide whether to authorize its two-doseCNBC
Nov 04 2021
Moderna Crash Wipes Out Another $24 Billion After Supply-Chain Issues Dent Covid Vaccine Sales
Moderna shares plummeted Thursday morning after the Cambridge, Massachusetts-based biotech firm posted worse-than-expected quarterly earnings and warned sales of its Covid-19 vaccines would fail to meet previous projections, fueling pessimism among analysts that warning the stock’s meteoric gains would fail to hold up amid supply-chain constraints as the pandemic wanes.
Oct 29 2020
Moderna reaches target goal of 30,000 vaccine trial participants, could apply for market in December
A Moderna COVID-19 vaccine clinical trial in the U.S. is underway and has reached the 30,000 participant target. The vaccine is one of four U.S vaccines in the phase 3 stage of trial.
The company says it's on track to apply for authorization from the Food and Drug Administration in early December if all requirements are met.
Of the 30,000 participants enrolled in the trial, halfJust The News